Absolutely stunning result from JCOG0802. Overall survival BETTER with segmentectomy than lobectomy for clinical stage I tumors </=2cm. More LR recurrences in segmentectomy, but more non-cancer deaths in lobectomy. Lots to consider. #lcsm#AATS2021
Amazing to see this preprint of the STOIC trial from @MonaBafadhel and colleagues.
Randomised Ph 2 trial of inhaled budesonide 800mcg bd (within 7 days of the onset of #COVID19 symptoms) reduced the relative risk of requiring urgent care by 90%.
medrxiv.org/content/10.1101/…